Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Gamma-aminobutyric Acid (GABA) Receptor Agonist - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Gamma-aminobutyric Acid (GABA) Receptor Agonist - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-11

Pages: 117 Pages

Report ld: 2634675

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.

The global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist was estimated to be worth US$ 163 million in 2023 and is forecast to a readjusted size of US$ 251.3 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030

Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size(US$)

M= millions and B=billions

Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gamma-aminobutyric Acid (GABA) Receptor Agonist by region & country, by Type, and by Application.

The Gamma-aminobutyric Acid (GABA) Receptor Agonist market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gamma-aminobutyric Acid (GABA) Receptor Agonist.

Market Segmentation

Report Metric
Details
Report Title
Gamma-aminobutyric Acid (GABA) Receptor Agonist - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 251.3 million
CAGR(2024-2030)
5.6%
Market Size Available for Years
2024-2030
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies Covered
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla
Aurobindo Pharma
Zydus Cadila
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, Segment by Type
Oral
Parenteral
Intrathecal
Others
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, Segment by Application
Hospitals
Specialty Clinics
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gamma-aminobutyric Acid (GABA) Receptor Agonist manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Gamma-aminobutyric Acid (GABA) Receptor Agonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Gamma-aminobutyric Acid (GABA) Receptor Agonist in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Introduction
    1.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Forecast
    1.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends & Drivers
        1.3.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Industry Trends
        1.3.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers & Opportunity
        1.3.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Challenges
        1.3.4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Players Revenue Ranking (2023)
    2.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Company (2019-2024)
    2.3 Key Companies Gamma-aminobutyric Acid (GABA) Receptor Agonist Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offered
    2.5 Key Companies Time to Begin Mass Production of Gamma-aminobutyric Acid (GABA) Receptor Agonist
    2.6 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Competitive Analysis
        2.6.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist as of 2023)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oral
        3.1.2 Parenteral
        3.1.3 Intrathecal
        3.1.4 Others
    3.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type
        3.2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, by Type (2019-2030)
        3.2.3 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Specialty Clinics
        4.1.3 Others
    4.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application
        4.2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, by Application (2019-2030)
        4.2.3 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region
    5.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region
        5.1.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region (2019-2024)
        5.1.3 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region (2025-2030)
        5.1.4 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        5.2.2 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        5.3.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        5.4.2 Asia Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        5.5.2 South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        5.6.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value
    6.3 United States
        6.3.1 United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        6.3.2 United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        6.4.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        6.5.2 China Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        6.6.2 Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        6.7.2 South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        6.8.2 Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019-2030
        6.9.2 India Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application, 2023 VS 2030

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Profile
        7.1.2 Sanofi Main Business
        7.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.1.4 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.1.5 Sanofi Recent Developments
    7.2 Mylan N.V.
        7.2.1 Mylan N.V. Profile
        7.2.2 Mylan N.V. Main Business
        7.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.2.4 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.2.5 Mylan N.V. Recent Developments
    7.3 Teva Pharmaceutical Industries
        7.3.1 Teva Pharmaceutical Industries Profile
        7.3.2 Teva Pharmaceutical Industries Main Business
        7.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.3.4 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.3.5 Novartis Recent Developments
    7.4 Novartis
        7.4.1 Novartis Profile
        7.4.2 Novartis Main Business
        7.4.3 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.4.4 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.4.5 Novartis Recent Developments
    7.5 Aytu BioScience
        7.5.1 Aytu BioScience Profile
        7.5.2 Aytu BioScience Main Business
        7.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.5.4 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.5.5 Aytu BioScience Recent Developments
    7.6 Dr. Reddy’s Laboratories
        7.6.1 Dr. Reddy’s Laboratories Profile
        7.6.2 Dr. Reddy’s Laboratories Main Business
        7.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.6.4 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.6.5 Dr. Reddy’s Laboratories Recent Developments
    7.7 Endo Pharmaceuticals
        7.7.1 Endo Pharmaceuticals Profile
        7.7.2 Endo Pharmaceuticals Main Business
        7.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.7.4 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.7.5 Endo Pharmaceuticals Recent Developments
    7.8 Lupin
        7.8.1 Lupin Profile
        7.8.2 Lupin Main Business
        7.8.3 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.8.4 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.8.5 Lupin Recent Developments
    7.9 Johnson & Johnson Services
        7.9.1 Johnson & Johnson Services Profile
        7.9.2 Johnson & Johnson Services Main Business
        7.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.9.4 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.9.5 Johnson & Johnson Services Recent Developments
    7.10 Lannett
        7.10.1 Lannett Profile
        7.10.2 Lannett Main Business
        7.10.3 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.10.4 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.10.5 Lannett Recent Developments
    7.11 Sun Pharmaceutical Industries
        7.11.1 Sun Pharmaceutical Industries Profile
        7.11.2 Sun Pharmaceutical Industries Main Business
        7.11.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.11.4 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.11.5 Sun Pharmaceutical Industries Recent Developments
    7.12 Cipla
        7.12.1 Cipla Profile
        7.12.2 Cipla Main Business
        7.12.3 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.12.4 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.12.5 Cipla Recent Developments
    7.13 Aurobindo Pharma
        7.13.1 Aurobindo Pharma Profile
        7.13.2 Aurobindo Pharma Main Business
        7.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.13.4 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.13.5 Aurobindo Pharma Recent Developments
    7.14 Zydus Cadila
        7.14.1 Zydus Cadila Profile
        7.14.2 Zydus Cadila Main Business
        7.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
        7.14.4 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$ Million) & (2019-2024)
        7.14.5 Zydus Cadila Recent Developments

8 Industry Chain Analysis
    8.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Industrial Chain
    8.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Model
        8.5.2 Sales Channel
        8.5.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends
    Table 2. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers & Opportunity
    Table 3. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Challenges
    Table 4. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
    Table 5. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Gamma-aminobutyric Acid (GABA) Receptor Agonist Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Type
    Table 9. Key Companies Time to Begin Mass Production of Gamma-aminobutyric Acid (GABA) Receptor Agonist
    Table 10. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma-aminobutyric Acid (GABA) Receptor Agonist as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region (2019-2024) & (%)
    Table 27. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2025-2030) & (US$ Million)
    Table 31. Sanofi Basic Information List
    Table 32. Sanofi Description and Business Overview
    Table 33. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Sanofi (2019-2024)
    Table 35. Sanofi Recent Developments
    Table 36. Mylan N.V. Basic Information List
    Table 37. Mylan N.V. Description and Business Overview
    Table 38. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Mylan N.V. (2019-2024)
    Table 40. Mylan N.V. Recent Developments
    Table 41. Teva Pharmaceutical Industries Basic Information List
    Table 42. Teva Pharmaceutical Industries Description and Business Overview
    Table 43. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Teva Pharmaceutical Industries (2019-2024)
    Table 45. Teva Pharmaceutical Industries Recent Developments
    Table 46. Novartis Basic Information List
    Table 47. Novartis Description and Business Overview
    Table 48. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Novartis (2019-2024)
    Table 50. Novartis Recent Developments
    Table 51. Aytu BioScience Basic Information List
    Table 52. Aytu BioScience Description and Business Overview
    Table 53. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Aytu BioScience (2019-2024)
    Table 55. Aytu BioScience Recent Developments
    Table 56. Dr. Reddy’s Laboratories Basic Information List
    Table 57. Dr. Reddy’s Laboratories Description and Business Overview
    Table 58. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Dr. Reddy’s Laboratories (2019-2024)
    Table 60. Dr. Reddy’s Laboratories Recent Developments
    Table 61. Endo Pharmaceuticals Basic Information List
    Table 62. Endo Pharmaceuticals Description and Business Overview
    Table 63. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Endo Pharmaceuticals (2019-2024)
    Table 65. Endo Pharmaceuticals Recent Developments
    Table 66. Lupin Basic Information List
    Table 67. Lupin Description and Business Overview
    Table 68. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Lupin (2019-2024)
    Table 70. Lupin Recent Developments
    Table 71. Johnson & Johnson Services Basic Information List
    Table 72. Johnson & Johnson Services Description and Business Overview
    Table 73. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Johnson & Johnson Services (2019-2024)
    Table 75. Johnson & Johnson Services Recent Developments
    Table 76. Lannett Basic Information List
    Table 77. Lannett Description and Business Overview
    Table 78. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Lannett (2019-2024)
    Table 80. Lannett Recent Developments
    Table 81. Sun Pharmaceutical Industries Basic Information List
    Table 82. Sun Pharmaceutical Industries Description and Business Overview
    Table 83. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Sun Pharmaceutical Industries (2019-2024)
    Table 85. Sun Pharmaceutical Industries Recent Developments
    Table 86. Cipla Basic Information List
    Table 87. Cipla Description and Business Overview
    Table 88. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Cipla (2019-2024)
    Table 90. Cipla Recent Developments
    Table 91. Aurobindo Pharma Basic Information List
    Table 92. Aurobindo Pharma Description and Business Overview
    Table 93. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Aurobindo Pharma (2019-2024)
    Table 95. Aurobindo Pharma Recent Developments
    Table 96. Zydus Cadila Basic Information List
    Table 97. Zydus Cadila Description and Business Overview
    Table 98. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Gamma-aminobutyric Acid (GABA) Receptor Agonist Business of Zydus Cadila (2019-2024)
    Table 100. Zydus Cadila Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Gamma-aminobutyric Acid (GABA) Receptor Agonist Downstream Customers
    Table 104. Gamma-aminobutyric Acid (GABA) Receptor Agonist Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Picture
    Figure 2. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value (2019-2030) & (US$ Million)
    Figure 4. Gamma-aminobutyric Acid (GABA) Receptor Agonist Report Years Considered
    Figure 5. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2023
    Figure 7. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Oral Picture
    Figure 9. Parenteral Picture
    Figure 10. Intrathecal Picture
    Figure 11. Others Picture
    Figure 12. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Specialty Clinics
    Figure 16. Product Picture of Others
    Figure 17. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value (%), (2019-2030)
    Figure 30. United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Value by Application (%), 2023 VS 2030
    Figure 51. Gamma-aminobutyric Acid (GABA) Receptor Agonist Industrial Chain
    Figure 52. Gamma-aminobutyric Acid (GABA) Receptor Agonist Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

Description

Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.

The global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist was estimated to be worth US$ 163 million in 2023 and is forecast to a readjusted size of US$ 251.3 million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030

Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gamma-aminobutyric Acid (GABA) Receptor Agonist by region & country, by Type, and by Application.

The Gamma-aminobutyric Acid (GABA) Receptor Agonist market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gamma-aminobutyric Acid (GABA) Receptor Agonist.

Market Segmentation

Related Reports

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Research Report 2024
Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.
Published: 2024-01-20
Pages: 89
USD 2900.00
(Single User License)
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Research Report 2025
The global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist was valued at US$ 190 million in the year 2024 and is projected to reach a revised size of US$ 277 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-02-07
Pages: 84
USD 2900.00
(Single User License)
Gamma-aminobutyric Acid (GABA) Receptor Agonist- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist was estimated to be worth US$ 190 million in 2024 and is forecast to a readjusted size of US$ 277 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 110
USD 3950.00
(Single User License)

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Research Report 2024
Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.
Published: 2024-01-20
Pages: 89
USD 2900.00 ()
Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Research Report 2025
The global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist was valued at US$ 190 million in the year 2024 and is projected to reach a revised size of US$ 277 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-02-07
Pages: 84
USD 2900.00 ()
Gamma-aminobutyric Acid (GABA) Receptor Agonist- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gamma-aminobutyric Acid (GABA) Receptor Agonist was estimated to be worth US$ 190 million in 2024 and is forecast to a readjusted size of US$ 277 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 110
USD 3950.00 ()